Literature DB >> 3076133

Current treatment guidelines for topical corticosteroids.

B Giannotti1.   

Abstract

The effectiveness of a topical corticosteroid is related to various factors which should be considered when planning treatment. The most relevant factor is the potency of the drug. Another important factor is the absorption through the skin, which is influenced by marked regional variations in percutaneous penetration, hydration and the degree of inflammation present, types of dressings, the solubility of the drug and the age of the patient. Multiple daily applications do not lead to better or faster resolution of the disease. Intermittent therapy with treatment-free intervals, when the vehicle alone is applied, can be as effective as continuous treatment. The choice of a topical corticosteroid depends not only on the severity or activity of the disease, but also on the age of the subject, the body site affected and the extent of the surface area to be treated. In addition, the choice of vehicle depends on the type of lesion and on the body region afflicted. Combinations of a corticosteroid with other agents can be useful, but they are recommended in only a few specific indications. Treatment guidelines for topical corticosteroids must therefore take into account a number of factors which will influence the clinician's ultimate decision in providing care for the patient with steroid-responsive dermatoses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3076133     DOI: 10.2165/00003495-198800365-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  19 in total

1.  EXISTENCE OF RESERVOIR IN THE STRATUM CORNEUM. EXPERIMENTAL PROOF.

Authors:  C F VICKERS
Journal:  Arch Dermatol       Date:  1963-07

2.  Analysis of the results obtained in the treatment of atopic dermatitis with corticosteroid and neomycin containing ointments.

Authors:  M K POLANO; H R DE VRIES
Journal:  Dermatologica       Date:  1960-04

3.  Topical steroids and bacterial infection.

Authors:  J A Savin
Journal:  Br J Dermatol       Date:  1976-03       Impact factor: 9.302

4.  Topical steroid-antibiotic combinations: assay of use in experimentally induced human infections.

Authors:  R R Marples; A Rebora; A M Kligman
Journal:  Arch Dermatol       Date:  1973-08

5.  Editorial: Topical corticosteroid therapy: efficacy of frequent application.

Authors:  W H Eaglstein; A Farzad; L Capland
Journal:  Arch Dermatol       Date:  1974-12

6.  [Results obtained from systematic interval therapy using corticoid-based materials (author's transl)].

Authors:  H P Huber; C Pflugshaupt
Journal:  Schweiz Rundsch Med Prax       Date:  1979-06-19

7.  The case for steroid--antibiotic combinations.

Authors:  J J Leyden; A M Kligman
Journal:  Br J Dermatol       Date:  1977-02       Impact factor: 9.302

8.  Treatment of psoriasis and atopic dermatitis with halcinonide cream applied once and three times daily.

Authors:  T Fredriksson; A Lassus; J Bleeker
Journal:  Br J Dermatol       Date:  1980-05       Impact factor: 9.302

9.  Topical corticosteroids: clinical pharmacology and therapeutic use.

Authors:  J A Miller; D D Munro
Journal:  Drugs       Date:  1980-02       Impact factor: 9.546

10.  Assay of topical corticosteroids. Efficacy of suppression of experimental Rhus dermatitis in humans.

Authors:  K H Kaidbey; A M Kligman
Journal:  Arch Dermatol       Date:  1976-06
View more
  4 in total

Review 1.  Topical corticosteroids. Which drug and when?

Authors:  B Giannotti; N Pimpinelli
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

Review 2.  Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.

Authors:  M Mori; N Pimpinelli; B Giannotti
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

3.  Rational and ethical use of topical corticosteroids based on safety and efficacy.

Authors:  Sanjay K Rathi; Paschal D'Souza
Journal:  Indian J Dermatol       Date:  2012-07       Impact factor: 1.494

4.  Ethical use of topical corticosteroids.

Authors:  Abir Saraswat
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.